Sign in

Trial result ·

Extended-Dose Letrozole Regimen<em> versus </em>Standard-Dose Regimen for Ovulation Induction and Biochemical Pregnancy in Polycystic Ovary Syndrome.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This trial tested the drug letrozole in 174 women with PCOS. The goal was to help the ovaries release an egg. By chance, 87 women took 5 mg on cycle days 2-10. The other 87 women took 5 mg on days 2-6. A hormone shot was given when the egg sacs were ready. Blood tests on day 21 and urine tests on day 28 checked results.

What they found

The groups were alike at the start. The longer course led to more women releasing an egg. It also led to more positive pregnancy tests. The study's stats tests found both gaps to be significant. Women with secondary subfertility were less likely to release an egg. No other factor they checked made a clear difference.

What it means for patients

The authors say the longer letrozole course worked better than the usual one. It helped more women release an egg and get a positive test. They also say the results should be read with care. The pregnancy tests here were early urine tests on day 28.

Why it is not certain yet

The authors warn that the study has limits. The abstract does not say what those limits are. It was done in one hospital with 174 women. Pregnancy was only checked by an early urine test. The abstract does not give results on live births or side effects.

Source

Extended-Dose Letrozole Regimen<em> versus </em>Standard-Dose Regimen for Ovulation Induction and Biochemical Pregnancy in Polycystic Ovary Syndrome.

PubMed · PMID 43016073

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Female infertility publications
Extended-Dose Letrozole Regimen<em> versus </em>Standard-Dose Regimen for Ovulation Induction and Biochemical Pregnancy in Polycystic Ovary Syndrome. · Female infertility news explained – Frontlight Research